Technology-enabled Research

Addressing the 64% Clinical Trial Data Incompleteness Rate in Observational Research

In this article with Clinical Trial Vanguard, our Chief Commercial Officer Rachael Thomas Higgins discusses how technology—particularly AI and virtual study models—can address the 64% data incompleteness rate in observational research by enabling continuous, patient-centric data collection and improving engagement. Check out the article to learn more!